EcoDrugPlus

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSPTIG00000006445
Gene Symbol: IGF1R
2 Cross references
274 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSPTIG00000007440
Gene Symbol: INSR
1 Cross references
288 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSPTIG00000019437
Gene Symbol: ITGA2B
2 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSPTIG00000017681
Gene Symbol: ITGA4
1 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSPTIG00000019878
Gene Symbol: ITGA5
1 Cross references
269 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSPTIG00000007747
Gene Symbol: ITGB1
2 Cross references
298 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSPTIG00000001432
Gene Symbol: ITGB3
2 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSPTIG00000020359
Gene Symbol: ITGB5
1 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSPTIG00000001109
Gene Symbol: ITGB6
2 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSPTIG00000007998
Gene Symbol: ITGB7
2 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSPTIG00000018464
Gene Symbol: ITGB8
2 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSPTIG00000013518
Gene Symbol: IRAK4
2 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).